Literature DB >> 33490200

A narrative review of electrical impedance tomography in lung diseases with flow limitation and hyperinflation: methodologies and applications.

Ling Sang1, Zhanqi Zhao2,3, Zhimin Lin1, Xiaoqing Liu1, Nanshan Zhong1, Yimin Li1.   

Abstract

Electrical impedance tomography (EIT) is a functional radiation-free imaging technique that measures regional lung ventilation distribution by calculating the impedance changes in the corresponding regions. The aim of the present review was to summarize the current literature concerning the methodologies and applications of EIT in lung diseases with flow limitation and hyperinflation. PubMed was searched up to May 2020 to identify studies investigating the use of EIT in patients with asthma, bronchiectasis, bronchitis, bronchiolitis, chronic obstructive pulmonary disease, and cystic fibrosis. The extracted data included study design, EIT methodologies, interventions, validation and comparators, population characteristics, and key findings. Of the 44 included studies, seven were related to simulation, animal experimentation, or reconstruction algorithm development with evaluation on patients; 27 studies had the primary objective of validating EIT technique and measures including regional ventilation distribution, regional EIT-spirometry parameters, end-expiratory lung impedance, and regional time constants; and 10 studies had the primary objective of applying EIT to monitor the response to therapeutic interventions, including various ventilation supports, patient repositioning, and airway suctioning. In pediatric and adult patients, EIT has been successfully validated for assessing spatial and temporal ventilation distribution, measuring changes in lung volume and flow, and studying regional respiratory mechanics. EIT has also demonstrated potential as an alternative or supplement to well-established measurement modalities (e.g., conventional pulmonary function testing) to monitor the progression of obstructive lung diseases, although the existing literature lacks prediction values as references and lacks clinical outcome evidence. 2020 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Asthma; chronic obstructive pulmonary disease; electrical impedance tomography; flow limitation and hyperinflation

Year:  2020        PMID: 33490200      PMCID: PMC7812189          DOI: 10.21037/atm-20-4984

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


Introduction

Patients with obstructive lung disease (OLD) have obstructive airways due to various causes, such as inflammation, excessive mucus, and airway deformation. Because of the resulting increase in airway resistance, flow limitation and hyperinflated lung regions are common manifestations of OLD. The two main kinds of OLD are asthma and chronic obstructive pulmonary disease (COPD); these conditions are highly prevalent and cause a substantial burden on the healthcare system, patients, and their relatives (1). OLD is generally diagnosed based on spirometry (2), which provides global information measured from the airway opening. However, as bronchial abnormalities often exhibit spatial non-uniformity that may be not assessed by spirometry, regional information may help to characterize the disease progress (3). Advanced imaging techniques (e.g., computed tomography, optical coherence tomography, and confocal laser endomicroscopy) are used to quantify structural alterations of the airways (4,5). However, these imaging techniques are not suitable for long-term monitoring due to their radiation load, procedural invasiveness, and high costs. Furthermore, these methods only measure the anatomical deterioration, which is not a direct measure of lung function (6). Electrical impedance tomography (EIT) is a functional radiation-free imaging technique that measures regional lung ventilation distribution by calculating the impedance changes in the corresponding regions (7). In recent years, the clinical use of EIT has been studied intensively (8-10), especially the use of EIT during mechanical ventilation (11), perioperative care (12), and in patients with acute respiratory distress syndrome (13). However, no review has focused on the use of EIT specifically in patients with OLD. We therefore conducted a review of the published literature on methodologies of EIT data analysis and the corresponding clinical applications in patients with flow limitation and lung hyperinflation. We present the following article in accordance with the NARRATIVE REVIEW reporting checklist (available at http://dx.doi.org/10.21037/atm-20-4984).

Methods

The PubMed database (www.ncbi.nlm.nih.gov) was searched using the keywords “electrical impedance tomography” or “EIT” combined with “obstructive lung”, “obstructive pulmonary”, “obstructive airway”, “obstructive sleep apnea”, “asthma”, “COPD”, “bronchiectasis”, “bronchitis”, “bronchiolitis”, or “cystic fibrosis”. Study titles and abstracts were screened for eligibility. Articles that were related to EIT technology and were clinically oriented were reviewed. Full texts of potentially eligible articles were retrieved. Only studies targeting patients with OLD and published as full-text articles in English journals were included. Study protocols, reviews, and editorial articles were excluded. Data from included studies were collected using a data abstraction form. Collected data included: (I) study details—author, publication year, design, objectives; (II) EIT details—purpose of use, measures, technical characteristics; (III) intervention details—validation and comparator (where applicable), intervention type (where applicable); (IV) population details—sample size, demographics; and (V) key findings.

Results and discussion

After removing duplicates, a total of 75 articles were identified. Title and abstract review led to the exclusion of 31 articles. All 44 included studies were related to OLD and EIT (). Seven studies were related to simulation, animal experimentation, or reconstruction algorithm development with evaluation on patients (). Twenty-seven studies were conducted to introduce and evaluate EIT-based measures, and assess the feasibility of using EIT in patients with OLD in the clinical setting (). Ten studies were designed to assess the effects of various therapies, ventilator strategies, and maneuvers (). EIT measures were used as the endpoints of the included studies.
Table 1

Summary of simulation and experimental studies related to obstructive lung diseases and EIT technique

First authorYearStudy typeSubjectsEIT measuresMain findings
Sahalos (14)1992Simulation, model prediction23 lung-healthy, 37 obstruction or restrictionPredicted impedanceThe percentage change in the measured input impedance from the predicted value is a good index to estimate the size of oedema and the physical state of the lungs (with model prediction)
Riedel (15)2006Experimental15 sheepROIs in 32 rows, filling index of left & right lungsSmoke inhalation caused immediate onset in pulmonary dysfunction and significant ventilation inhomogeneity
Schullcke (16)2017Simulation3D model; 1 CF pat.‘lobe reconstruction’ algorithmThe approach enhances common reconstruction methods by providing information about anatomically assignable units and thus facilitates image interpretation
Schullcke (17)2018Simulation3D modelGI, CVMinor obstruction outside electrode plane may not be recognized. Multi-planes measurement should be considered
Ayoub (18)2019Algorithm development7 healthy 10 OSA subjectsReconstruction algorithmquantitative information about changes in the size and shape during upper airway closing and opening for OSA phenotype and treatment plan
Secombe (19)2019Experimental6 healthy horsesGlobal & regional flowStandardized changes in airflow during histamine challenge could be detected using EIT gas flow variables. EIT could be used to monitor bronchoconstriction and bronchoprovocation
Ayoub (20)2020Algorithm10 OSAautomatic data processing and feature extract methodsCharacterized the upper airway dynamics during sleep apnea

CF, cystic fibrosis; CV, Coefficients of variation; GI, global inhomogeneity index; OSA, obstructive sleep apnea; ROI, region of interest.

Table 2

Summary of studies that introduced and evaluated EIT-based measures, the feasibility of EIT technique in clinical applications of patients with flow limitation and hyperinflation

First authorYearDesignSubjectsInterventionEIT measuresMain findings
Eyüboðlu (21)1995Observational15 lung-healthy, 12 COPDPFT, 2nd, 4th, 6th ICSΔZ normalized to TLCThe emphysematous bulla, the tumour structure, and COPD result in the same type of defect in the test images and are therefore indistinguishable from each other. EIT may be a useful screening device in detecting emphysema rather than a diagnostic tool
Vonk Noordegraaf (22)1997Observational7 lung-healthy, 35 COPDMRI, right-sided heart catheterizationRAEVRAEV measured by EIT is a useful noninvasive and inexpensive method for assessing right ventricular diastolic function in COPD patients
Smit (23)2003Observational7 lung-healthy & 6 COPDChanges in oxygen levels (21%–100%)Maximal impedance change during systoleEIT can detect blood volume changes due to HPV noninvasively in healthy subjects and hyperoxic vasodilation in COPD patients
Smit (24)2003Observational24 healthy 6 patients (1 asthma 4 COPD, 1 pulmonary hypertension, 1 fibrosis)ECG gated EIT, repeated measurements with light physical activities in betweenΔZ and number of pixels in various ROIs for lung perfusionCardiac related pulsatility signals are highly reproducible when performed by the same investigator as well as by two different investigators
Smit (25)2004Observational17 lung-healthy & 10 COPD & 10 heart failureVTmaximal pulmonary pulsatile blood volume during systoleThe EIT signal likely reflects the size of the pulmonary microvascular bed, since neither a low cardiac output nor a change in SV of the heart appear to influence EIT
Zhao (26)2012Observational14 lung-healthy & 14 CFPFTGI, regional MEF25/MEF75EIT is able to deliver both global and regional information to assess the airway obstruction in CF patients
Vogt (27)2012Observational26 lung-healthy & 33 COPDPFTRegional IVC, FVC, FEV1, FEV1/FVC, t25, t50, t75, t90, VTEIT may provide additional information during pulmonary function testing and identify pathologic and age-related spatial and temporal heterogeneity of regional lung function
Marinho (28)2013Case1 bronchial stenosisnasal CPAP, postural changesLeft vs. Right ratioThe EIT assessment of regional lung ventilation produced results similar to those obtained with the radionuclide imaging technique and had the advantage of providing a dynamic evaluation without radiation exposure
Zhao (6)2013Observational5 CFPFT, CTMEF25/MEF75Regional airway obstruction identified in the MEF25/MEF75 maps was similar to that found in CT
Lehman (29)2014Case1 CF childpre- and postoperativeGlobal and regional FVC, FEV1, FEV1/FVCThe present case study documents the utilization of routine diagnostic tools in comparison with EIT and indicates a good correlation
Vogt (30)2016Observational13 healthy & 15 OLDStable VT, various torso and Arm PositionsEELI, TV, CVThe forward torso movement and the arms' abduction exert significant effects on the EIT waveforms during tidal breathing. When EIT is used during PFT, strict adherence to the upright sitting position
Vogt (31)2016Observational35 COPDPFT, reversibility testingGlobal & regional FEV1/FVC and t50, t75By providing regional data, EIT might increase the diagnostic and prognostic information derived from reversibility testing
Frerichs (32)2016Observational7 healthy & 7 chronic asthma adultsPFT, reversibility testingGlobal & regional FEV1/FVC and t50, t75The examination of regional lung function using EIT enables the assessment of spatial and temporal heterogeneity of ventilation distribution during bronchodilator reversibility testing
Krueger-Ziolek (33)2016Observational10 lung-healthy & 10 CFPFT, 3rd & 5th ICSregional FEV1/FVCResults indicated that EIT measurements at more cranial thorax planes may benefit the early diagnosis in CF
Lehmann (34)2016Observational11 CF, 11 healthyPFT, BSLGlobal and regional “EIT-spirometry”EIT-spirometry correlated with lung function parameters, clinical findings, and radiology and was able to visualize individual therapeutic effects
De la Oliva (35)2017CasebronchospasmPeri-operativeTime constant, CoVBreath-wise EIT-based time constant images may quickly identify bronchospasm at the bedside, which could improve perioperative patient management and safety
Karagiannidis (36)2018Observational14 MV patients (7 COPD)PEEP adjustmentGlobal tidal variation, expiratory time constantsBreath-by-breath regional expiratory time constants is feasible, which could be used to adjust mechanical ventilation according to regional airflow obstruction
Lehmann (37)2018Observational1 pediatric CF, 6 healthyMV for the CF case, positioning for healthyTV dorsal/TV totalTherapeutic recommendations for positioning are available considering gravitational influences on lung ventilation. They can be contradictory depending on the underlying lung disease, which can be guided by EIT
Muller (38)2018Observational21 CF, 14 healthyPFTGlobal and regional TV, FEV1, FVC, and FEV1/FVC; Spatial CVCV for tidal breathing might be used to distinguish between healthy subjects and CF patients
Mueller (39)2018Observational2 CF, 1 healthyCTVentilation/perfusion mappingEIT-derived ventilation-perfusion index maps can be used to identify regions of air trapping
Ngo (40)2018Observational58 health 58 asthma childrenPFTGlobal & regional FEV1/FVC, FV loopGlobal FV loops derived from EIT correlate well with spirometry. Positive BSL can be observed in EIT-derived FV loops
Vogt (41)2018Observational100 lung-healthy & 3 CF childrenPFT, physical exerciseGlobal & regional FEV1/FVC and times required to exhale 50% and 75% of pixel FVCThe obtained EIT-derived regional lung parameters can serve as reference values for future studies in children with lung diseases
Zhang (42)2018Observational41 lung-healthy & 67 OLD adultsPFTGlobal & regional FEV1/FVCEIT has the potential to evaluate the degree of obstruction in OLD patients on the global and regional level
Kim (43)2019Observational17 healthy,10 OSASwallowing or airway collapse during sleep, MRI, PSGΔZ. The location of electrodes are at the lower face instead of chestEIT can quantify upper airway collapse in terms of its size during natural sleep
Milne (44)2019Observational11 lung-healthy & 9 COPDPFT with spirometry & FOTAMP, PHASE, tETime-based EIT measurements that not only demonstrate ventilation heterogeneity in COPD, but also reflect oscillatory lung mechanics
Zhao (45)2020Observational18 COPD & 7 asthmaMVRegional EEFRegional EEF characterizes air trapping and intrinsic PEEP, which could provide diagnostic information for monitoring the disease progress during treatment
Zhang (46)2020Observational10 lung-healthy, 10 RMW, 10 COPD,PFTGlobal VC, FVC, MVVEIT electrode belt could reduce lung volumes in subjects with pre-existing lung diseases. Comparing lung function acquired with electrode belt to corresponding values obtained without the belt should be avoided

AMP, mean amplitude of impedance-time curve tidal variation; BSL, bronchospasmolysis; CF, cystic fibrosis; COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway pressure; CV, coefficient of variation; ΔZ, relative impedance change; ECG, electrocardiogram; EEF, end-expiratory flow; EELI, end-expiratory lung impedance; FEV1, forced expiratory volume in 1 second; FOT, forced oscillation technique; FVC, forced vital capacity; HFNC, high-flow nasal cannula; HPV, hypoxic pulmonary vasoconstriction; ICS, intercostal space; IVC, inspiratory vital capacity; LPV, lung protective ventilation; MEFx, maximum expiratory flow at x% of vital capacity; MMV, maximum voluntary ventilation; MV, mechanical ventilation; OSA, obstructive sleep apnea; PEEP, positive end-expiratory pressure; PEP, positive expiratory pressure; PFT, pulmonary function test; PHASE, mean time difference between pixel and global impedance-time curves; PSG, polysomnography; PSV, pressure support ventilation; RAEV, the right atrium emptying volume; RMW, respiratory muscle weakness; ROI, regional of interest; SB, spontaneous breathing; tE, mean expiratory time; TLC, total lung capacity; tx, times required to expire x% of FVC; VC, slow expiratory vital; capacity

Table 3

Summary of studies that used EIT as study end-points

First authorYearDesignSubjectsInterventionEIT measuresMain findings
Filho (47)2010Case1 emphysema premature newbornHFOVfEITFunctional abnormalities may persist for longer periods after radiologic resolution of such lesions
Frerichs (48)2012Observational10 COPDHFOVTV, Ventral vs. Dorsal ratio, CoVShort-term HFOV, using lower mean airway pressures than recommended for ARDS, appears safe in patients with COPD while securing adequate pulmonary gas exchange
Hough (49)2014Observational13 infants with bronchiolitisHFNCEELI, TVIn infants with bronchiolitis, HFNC oxygen/air delivered at 8 L/min resulted in increases in end-expiratory lung volume and improved respiratory rate, FiO2, and SpO2
Wettstein (50)2014Randomized cross-over9 CF and 11 healthySB, CPAP PEP; upright or lateral positionsFI, EELI, left: right ratio, TVPEP shows distinct differences to CPAP with respect to its impact on ventilation distribution in healthy adults and CF subjects
Bongiovanni (51)2016Observational15 OSAPSGglobal ΔZ and ROIsGlobal ΔZ higher in Wake vs. Sleep, in NREM vs. REM, in OSA vs. non-OSA
Kostakou (52)2016Case1 AECOPD, Dynamic hyperinflationPressure control ventilation, PEEP titrationRVDPEEP selected with RVD achieved the highest expired tidal volume and the lowest airway resistance
Krueger-Ziolek (53)2017Observational12 lung-healthy & 12 CFVTventilation and pulsatile impedance ratioHigher breathing efforts of the CF patients due to airway obstruction may lead to higher intrathoracic pressures, and thus to greater changes in lung perfusion
Sun (54)2017Observational15 AECOPD3 levels PSV & NAVA% in ROI (ventral, mid-ventral, mid-dorsal, and dorsal)NAVA was superior to PSV in AECOPD for increasing ventilation distribution in ROI4 and reducing dead space
Roethlisberger (55)2018Observational20 CF childrenBody plethysmography, nitrogen multiple-breath washoutEELIThe application of elastic chest wall restriction is safe, induces the intended decline in resting lung volume but does not systematically alter ventilation inhomogeneity in children with CF
Ringer (56)2020Randomized cross-over16 infants with bronchiolitisNasal aspiration and nasopharyngeal suctioningEELI, TVInfants with viral bronchiolitis appeared to tolerate both suctioning techniques without adverse short-term physiologic effects, as indicated by the unchanged gas exchange and estimated lung volumes

AECOPD, acute exacerbation of chronic obstructive pulmonary disease; ARDS, acute respiratory distress syndrome; CF, cystic fibrosis; CoV, center of ventilation; CPAP, continuous positive airway pressure; EELI, end-expiratory lung impedance; FI, filling index; FiO2, fraction of inspiration oxygen; HFOV, high-frequency oscillatory ventilation; NAVA, neurally adjusted ventilatory assist; NREM, non-rapid eye movements; OSA, obstructive sleep apnea; ROI, region of interest; RVD, regional ventilation delay; SpO2, peripheral capillary oxygen saturation; TV, tidal variation.

CF, cystic fibrosis; CV, Coefficients of variation; GI, global inhomogeneity index; OSA, obstructive sleep apnea; ROI, region of interest. AMP, mean amplitude of impedance-time curve tidal variation; BSL, bronchospasmolysis; CF, cystic fibrosis; COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway pressure; CV, coefficient of variation; ΔZ, relative impedance change; ECG, electrocardiogram; EEF, end-expiratory flow; EELI, end-expiratory lung impedance; FEV1, forced expiratory volume in 1 second; FOT, forced oscillation technique; FVC, forced vital capacity; HFNC, high-flow nasal cannula; HPV, hypoxic pulmonary vasoconstriction; ICS, intercostal space; IVC, inspiratory vital capacity; LPV, lung protective ventilation; MEFx, maximum expiratory flow at x% of vital capacity; MMV, maximum voluntary ventilation; MV, mechanical ventilation; OSA, obstructive sleep apnea; PEEP, positive end-expiratory pressure; PEP, positive expiratory pressure; PFT, pulmonary function test; PHASE, mean time difference between pixel and global impedance-time curves; PSG, polysomnography; PSV, pressure support ventilation; RAEV, the right atrium emptying volume; RMW, respiratory muscle weakness; ROI, regional of interest; SB, spontaneous breathing; tE, mean expiratory time; TLC, total lung capacity; tx, times required to expire x% of FVC; VC, slow expiratory vital; capacity AECOPD, acute exacerbation of chronic obstructive pulmonary disease; ARDS, acute respiratory distress syndrome; CF, cystic fibrosis; CoV, center of ventilation; CPAP, continuous positive airway pressure; EELI, end-expiratory lung impedance; FI, filling index; FiO2, fraction of inspiration oxygen; HFOV, high-frequency oscillatory ventilation; NAVA, neurally adjusted ventilatory assist; NREM, non-rapid eye movements; OSA, obstructive sleep apnea; ROI, region of interest; RVD, regional ventilation delay; SpO2, peripheral capillary oxygen saturation; TV, tidal variation.

Conducting measurements

The included studies described several measurement settings. Depending on the manufacturer of the EIT system, the number of electrodes varied from 16 to 32; for example, 16 electrodes were used with the PulmoVista 500 (Dräger Medical, Lübeck, Germany) (45), Sheffield Mark I (IBEES, Sheffield, England) (22), GeoMF II (Cardinal Health, Hoechberg, Germany) (48), KHU Mark2.5 (IIRC, Seoul, Korea) (43), Dixtal Enlight (Timpel Medical, São Paulo, Brazil) (28), and PEIT4, (FMMU, Xi’an, China) (42), 
while 32 electrodes were used with the Swisstom BB2 (SenTec AG, Landquart, Switzerland) (36). The electrodes were placed around the chest at the 4th to 6th intercostal spaces in most cases, except in three studies of patients with obstructive sleep apnea (OSA), where the electrodes were placed around the lower head above the neck to measure the airway occlusion (18,20,43). As the impedance-volume ratio may be significantly influenced by the position of the electrode plane and volume excursion (57,58), we strongly advise against the placement of electrodes lower than the 5th intercostal space during spirometry testing. Furthermore, an adjacent current injection pattern is used for the setup of a 16-electrode system, whereas a skip-4 injection pattern is used for a 32-electrode system.

EIT data evaluation

Impedance values are presented as the relative time-difference with arbitrary units, i.e., ΔZ = (Zt_1 − Zt_ref)/Zt_ref. The relative impedance change (ΔZ) always refers to the impedance of a previous reference timepoint (Zt_ref). However, normalization with Zt_ref might be skipped in some presentations. Most EIT systems were developed to monitor spatial ventilation heterogeneity; therefore, the EIT data is usually illustrated as the global impedance-time curve (sum of ΔZ from all pixels against time) and regional impedance-time curves (sum of ΔZ from regions of interest against time) (, right images). End-expiratory lung impedances before and after certain maneuvers that reflect the change in end-expiratory lung volume are often compared to evaluate the effects of the maneuvers (49,55,56). Tidal variation (TV), which corresponds to tidal volume, is calculated by subtracting the end-expiratory global impedance from the end-inspiratory global impedance. Patients with OLD typically show ventilation delay due to airway occlusion or increased mucus production, which requires extra analysis. Hence, the EIT data was evaluated offline in most included studies.
Figure 1

Functional EIT images representing tidal variation (left) and relative impedance (ΔZ) curves (right) from one patient with acute exacerbation of chronic obstructive pulmonary disease under assist-control ventilation. The tidal variation does not change much before versus after bronchodilator administration (left top vs. left bottom image). The global impedance curve shows a decrease in end-expiratory lung impedance 60 minutes post-bronchodilation (right top image), mainly caused by the changes in the dorsal regions (right bottom image) rather than the ventral regions (right middle image). EIT, electrical impedance tomography; AU, arbitrary unit.

Functional EIT images representing tidal variation (left) and relative impedance (ΔZ) curves (right) from one patient with acute exacerbation of chronic obstructive pulmonary disease under assist-control ventilation. The tidal variation does not change much before versus after bronchodilator administration (left top vs. left bottom image). The global impedance curve shows a decrease in end-expiratory lung impedance 60 minutes post-bronchodilation (right top image), mainly caused by the changes in the dorsal regions (right bottom image) rather than the ventral regions (right middle image). EIT, electrical impedance tomography; AU, arbitrary unit.

Spatial ventilation distribution

Spatial ventilation distribution is usually analyzed based on functional EIT images representing tidal ventilation (, left images). One study discussed various types of tidal EIT (59). A direct summary of spatial ventilation distribution was achieved by calculating the global inhomogeneity (GI) or center of ventilation (CoV) indices. The GI index quantifies the tidal ventilation distribution within the lung regions identified in tidal EIT images (60). The GI index is calculated from the tidal EIT images using the following equation: where DI denotes the value of the differential impedance in the tidal images, DI is the pixel in the identified lung area, and DI are all the pixels representing the lung area. A high GI index implies large variations among pixel tidal impedance values, indicating heterogeneous ventilation (17,26). The identification of the lung area is a prerequisite for the calculation of the GI index. Any incorrect identification of the lung area omitting some sections of the lungs that are poorly or non-ventilated will decrease the apparent heterogeneity; this leads to a reduced ability of the GI index to distinguish “true” heterogeneity from the apparent effect due to the incorrect identification of lung regions. The CoV characterizes the ventilation distribution in the ventrodorsal direction (61), as calculated using the following equation: where ΔZj is the image value in pixel j, and yj is the height of pixel j scaled so that the bottom of the image is 0% and the top is 100%. The CoV is an intuitive index that compares the change in ventilation (35), especially when the tidal volume is constant. The CoV is sometimes simplified as the sum of the pixel TV values in the dorsal half of the image as a fraction of the global sum of the pixel TV values in the whole image (37). However, this simplification is less sensitive than the actual CoV, and so should not be termed “CoV” (62).

Temporal ventilation heterogeneity

Obstructive airways may delay the delivery of air to the alveoli. EIT with high temporal resolution is able to capture such delays. The regional ventilation delay (RVD) quantifies the time delay needed for the regional impedance-time curve to reach a certain threshold of the maximal local impedance (63). As illustrated in , the RVD highlights the change in the lung status after treatment. The RVD may help to identify the positive end-expiratory pressure (PEEP) level with the largest expired tidal volume and the lowest airway resistance in patients with acute exacerbation of COPD (52). Similarly, the regional time delay and regional expiratory time are correlated to the oscillatory impedance measured by the forced oscillation technique (44). During the forced vital capacity (FVC) maneuver, the time required to expire x% of the FVC is often calculated to show the temporal heterogeneity in patients with OLD (27), and as a measure of the efficacy of bronchodilator administration (31,32). The intra-tidal ventilation distribution (ITVD) shows the ventilation heterogeneity during inspiration (64). The left image in shows that the ITVD illustrates the temporal ventilation heterogeneity from another aspect to the RVD. Sun et al. found that the ventilation in the most dependent lung regions may be associated with diaphragm activity (54). However, while Zhao et al. evaluated the ΔZ of the whole tidal breath, the division of the ITVD into the inspiration in several time periods may provide more complex information regarding diaphragm activity (65), which may be useful in the assessment of patients with spontaneous breathing. Another measure used to evaluate temporal heterogeneity is the regional time constant, which reflects changes in regional lung mechanics (resistance × compliance) (35,36). The impedance-time curves are fitted using the following equation:
Figure 2

Regional ventilation delay (RVD; left) and intra-tidal ventilation distribution (ITVD; right) analysis of the same patient as in . RVD maps reveal that the inspiration started soonest in the dorsal regions after bronchodilation (green regions in the left bottom image). ITVD analysis shows that the dorsal regions (gravity-dependent regions) fill faster during inspiration after bronchodilation.

Regional ventilation delay (RVD; left) and intra-tidal ventilation distribution (ITVD; right) analysis of the same patient as in . RVD maps reveal that the inspiration started soonest in the dorsal regions after bronchodilation (green regions in the left bottom image). ITVD analysis shows that the dorsal regions (gravity-dependent regions) fill faster during inspiration after bronchodilation. where Z(t) denotes the impedance at timepoint t, Z0 is the impedance at the start of the fitting period, t represents the time during the fitting period, τ is the time constant, and k is the impedance value at the end of the fitting period. The regional time constant may be altered not only in patients with OLD, but also in patients with lung compliance changes (e.g., acute respiratory distress syndrome). The temporal heterogeneity is often presented as a histogram of the coefficient of variation and frequency distributions (27,38); such presentations could also be used for other evaluation categories.

Flow limitation

The rationale of the lung EIT technique is based on the assumption of a linear relationship between ΔZ and lung volume changes during inspiration and expiration, as validated in previous studies (66,67). Therefore, the derivatives of ΔZ are considered to be proportional to the inspiratory and expiratory flows. Flow limitation is a well-known symptom of OLD (2). EIT captures regional flow limitations and provides unique information that cannot be obtained using other techniques. The most widely studied parameters are obtained via EIT-based spirometry, including the forced expiratory volume in 1 second (FEV1), FVC, and maximum expiratory flow at x% of the vital capacity (6,26,27,31,32,42). In addition, regional flow-volume loops may show inhomogeneous flow limitation among different regions of interest (40). These EIT-based spirometry parameters are calculated in a similar manner to their original definitions, except that the regional ΔZ and ΔZ' are used as substitutes for the volume and flow. The regional lung function map provides an intuitive way to understand the patient’s status (). In patients with OLD under mechanical ventilation, flow limitation often prevents the end-expiratory flow from returning to zero. Regional end-expiratory flow may be associated with air trapping and intrinsic PEEP, and provide diagnostic information for monitoring the disease progress during treatment (45).
Figure 3

Functional EIT images showing the spatial ventilation distribution during tidal breathing (tidal variation; left) and the regional spirometry parameters (FEV1/FVC; right) in a healthy volunteer (top row) and a patient with chronic obstructive pulmonary disease (COPD) (bottom row). Highly ventilated regions are marked with light blue in the tidal variation maps (left). Scale is in arbitrary units. Regions with a high FEV1/FVC ratio are marked with light yellow in the EIT-based regional spirometry maps (right). Although the spatial ventilation distribution seems unaffected, the regional lung function defect is easily identifiable, especially in the left lung where the regional FEV1/FVC is much lower. FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.

Functional EIT images showing the spatial ventilation distribution during tidal breathing (tidal variation; left) and the regional spirometry parameters (FEV1/FVC; right) in a healthy volunteer (top row) and a patient with chronic obstructive pulmonary disease (COPD) (bottom row). Highly ventilated regions are marked with light blue in the tidal variation maps (left). Scale is in arbitrary units. Regions with a high FEV1/FVC ratio are marked with light yellow in the EIT-based regional spirometry maps (right). Although the spatial ventilation distribution seems unaffected, the regional lung function defect is easily identifiable, especially in the left lung where the regional FEV1/FVC is much lower. FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.

Cardiac-related signals

High temporal resolution allows EIT to study not only ventilation but also faster physiological phenomena, such as pulmonary perfusion and the pulsatility of the lung during the cardiac cycle (68,69). Cardiac-related signals are highly reproducible in COPD (22-25). Vonk Noordegraaf et al. showed that the ratio of the volume change during the rapid filling phase to the total ventricular filling volume measured by EIT can be used to assess the right ventricular diastolic function (22). Recently, another group calculated the ventilation/perfusion mismatch based on cardiac-related pulsatility changes to estimate air trapping (39). The pulsatility method measures the amplitude of the cyclic perturbations in local lung impedance caused by the passage of the stroke volume through the lung. Lung pulsatility is also significantly influenced by the distensibility of the pulmonary vessels and the size and patency of the pulmonary microvascular bed (70). Therefore, pulsatility-based methods might be misleading as a measure of pulmonary perfusion in patients with collapse of small pulmonary vessels or substantial changes in the parenchymal architecture. Another EIT-based method using hypertonic saline bolus injection seems to be promising as a measure of lung perfusion (69,71).

Clinical applications

Lung function testing

As described in the previous section, the main application of EIT for patients with flow limitation and lung hyperinflation is in the field of lung function testing (spirometry). As summarized in , simultaneous measurement of EIT and spirometry provides not only global absolute volume and flow limitations, but also regional relative alterations caused by the disease or in response to treatment. The absolute values determined by spirometry can be used to normalize ΔZ and ΔZ' to milliliters and milliliters per second. To assess the changes in functional residual capacity and residual volume, body plethysmography is used instead of spirometry. One study described the modification of a body plethysmography device to allow the simultaneous measurement of EIT and absolute lung volume to evaluate the influence of the electrode plane on EIT data (57). Such a novel combined system enables the simultaneous assessment of global and regional lung function, which may provide new possibilities in the diagnosis and prognosis of pulmonary diseases. Nevertheless, as such modification is not standard, the clinical gain versus cost needs to be evaluated in further studies. The forced oscillation technique (FOT) superimposes forced oscillation signals at the airway opening to determine the mechanical impedance of the respiratory system. The FOT is often used to examine the lung function of patients with OLD (72). A measurement modality that combines the FOT and EIT has recently been introduced (73). The correlation between EIT and FOT results suggests that such a combination is a promising future way to evaluate the respiratory system (44). The effect of bronchodilator administration on flow limitation is usually assessed by spirometry. In the era of EIT, besides the shape of the flow-volume loop, the heterogeneity of lung function parameters in various lung regions provides deeper understanding of the drug efficacy. Patients with asthma and COPD show not only a reduction in the absolute value of flow, but also a less homogeneous regional lung function compared with healthy subjects (31,32). Spatial and temporal ventilation distribution is improved after bronchodilator administration in patients with asthma and partially improved in patients with COPD, as evidenced by the histograms of pixel FEV1/FVC values and pixel expiration times. Further study may focus on the utility of this novel information for diagnosis and disease progress monitoring. As the forced maneuvers in lung function testing are highly dependent on the motivation and effort of the patients, future research may focus on the ability of EIT to assess regional lung function without the need for forced maneuvers. Our unpublished data from 60 patients with COPD suggests that the parameters of spatial heterogeneity obtained from quiet tidal breathing are comparable to the measures derived from the forced maneuvers.

Patients receiving ventilation support

Patients with severe COPD or asthma may require ventilation support. Several studies have shown that regional air trapping and intrinsic PEEP can be visualized with EIT (39,45,74). Furthermore, two studies evaluated the use of EIT to guide PEEP adjustment in OLD (36,52). Temporal information (e.g., regional delay in ventilation and expiratory time constants) can be considered to optimize PEEP to reduce flow limitation. The influences of various ventilation supports on the respiratory system have also been evaluated with EIT-based measures (47-49,54), which helps clinicians to choose the appropriate ventilation mode or type of support for patients with flow limitation and lung hyperinflation. Frerichs et al. used EIT to monitor ventilation during high-frequency oscillatory ventilation, which could not be achieved by other techniques due to the high temporal dynamics (48). They found that ventilation is more homogeneously distributed during high-frequency oscillatory ventilation than during initial conventional mechanical ventilation (48). In addition, the EIT technique is becoming more popular in infants and children, as the diagnostic and monitoring options for the respiratory system are more limited in pediatric patients compared with adults. One study showed that a high-flow nasal cannula leads to increases in end-expiratory lung volume and improvements in respiratory rate, fraction of inspiration oxygen, and peripheral capillary oxygen saturation in infants with bronchiolitis (49); in addition, suctioning techniques do not negatively affect lung volume in the same patient group (56). Furthermore, neurally adjusted ventilatory assist is superior to PSV for increasing ventilation distribution in the most dorsal regions and reducing dead space in patients with acute exacerbation of COPD (54). Pendelluft is caused by different regional time constants or dynamic pleural pressure variations in spontaneously breathing patients. We recently introduced an EIT-based method to evaluate the degree of pendelluft, thus enabling visualization of the improvement in airway obstruction after treatment (75). This information might be correlated to that derived from the time constant; this issue requires further investigation.

OSA

OSA is usually diagnosed using polysomnography in the sleep laboratory. This labor-intensive diagnosis requires overnight hospitalization, which makes in-laboratory sleep studies expensive and inconvenient. Home sleep testing is a cost-effective alternative used to diagnose moderate to severe sleep apnea; however, the reduced measurements often fail to accurately stratify the severity of the breathing disorder. EIT offers new and accurate information in addition to both polysomnography and home sleep testing by adding lung volume signals to quantify apnea and hypopnea (76). EIT around the chest wall shows that lung volume changes differ between those with versus without OSA (51). Furthermore, new electrode placement designs and reconstruction algorithms enable the detection of upper airway collapse (18,20,43).

Limitations

Our study has certain limitations. The literature search may have missed pertinent articles due to the selection of the search terms. Furthermore, potentially relevant articles published in languages other than English were not included. Finally, the included studies share a common limitation of small sample size, which may limit their validity.

Conclusions

In pediatric and adult patients, EIT has been successfully validated for assessing spatial and temporal ventilation distribution, measuring changes in lung volume and flow, and studying regional respiratory mechanics. EIT has also been demonstrated to be a viable alternative or supplement for well-established measurement modalities (e.g., conventional pulmonary function test) to track the progression of OLD, although the existing literature lacks prediction values as references and lacks clinical outcome evidence. The article’s supplementary files as
  76 in total

Review 1.  The forced oscillation technique in clinical practice: methodology, recommendations and future developments.

Authors:  E Oostveen; D MacLeod; H Lorino; R Farré; Z Hantos; K Desager; F Marchal
Journal:  Eur Respir J       Date:  2003-12       Impact factor: 16.671

2.  Electrical impedance tomography to measure pulmonary perfusion: is the reproducibility high enough for clinical practice?

Authors:  H J Smit; M L Handoko; A Vonk Noordegraaf; Th J C Faes; P E Postmus; P M J M de Vries; A Boonstra
Journal:  Physiol Meas       Date:  2003-05       Impact factor: 2.833

3.  Evaluation of an electrical impedance tomography-based Global Inhomogeneity Index for pulmonary ventilation distribution.

Authors:  Zhanqi Zhao; Knut Möller; Daniel Steinmann; Inéz Frerichs; Josef Guttmann
Journal:  Intensive Care Med       Date:  2009-08-04       Impact factor: 17.440

4.  Electrical impedance tomography as possible guidance for individual positioning of patients with multiple lung injury.

Authors:  Sylvia Lehmann; Steffen Leonhardt; Chuong Ngo; Lukas Bergmann; Simone Schrading; Konrad Heimann; Norbert Wagner; Klaus Tenbrock
Journal:  Clin Respir J       Date:  2016-05-06       Impact factor: 2.570

Review 5.  Thoracic electrical impedance tomography in Chinese hospitals: a review of clinical research and daily applications.

Authors:  Zhanqi Zhao; Feng Fu; Inéz Frerichs
Journal:  Physiol Meas       Date:  2020-05-04       Impact factor: 2.833

6.  Noninvasive assessment of right ventricular diastolic function by electrical impedance tomography.

Authors:  A Vonk Noordegraaf; T J Faes; A Janse; J T Marcus; J G Bronzwaer; P E Postmus; P M de Vries
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

7.  Persistence of ventilatory defect after resolution of pulmonary interstitial emphysema in a preterm baby.

Authors:  Luiz Vicente Ferreira da Silva Filho; Felipe De Souza Rossi; Alice d'Agostini Deutsch; Ana Cristina Zanon Yagui; Karina Timenetsky; Celso de Moura Rebello
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

8.  Regional lung perfusion as determined by electrical impedance tomography in comparison with electron beam CT imaging.

Authors:  Inéz Frerichs; José Hinz; Peter Herrmann; Gerald Weisser; Günter Hahn; Michael Quintel; Gerhard Hellige
Journal:  IEEE Trans Med Imaging       Date:  2002-06       Impact factor: 10.048

9.  Regional lung function determined by electrical impedance tomography during bronchodilator reversibility testing in patients with asthma.

Authors:  I Frerichs; Z Zhao; T Becher; P Zabel; N Weiler; B Vogt
Journal:  Physiol Meas       Date:  2016-05-20       Impact factor: 2.833

10.  Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group.

Authors:  Inéz Frerichs; Marcelo B P Amato; Anton H van Kaam; David G Tingay; Zhanqi Zhao; Bartłomiej Grychtol; Marc Bodenstein; Hervé Gagnon; Stephan H Böhm; Eckhard Teschner; Ola Stenqvist; Tommaso Mauri; Vinicius Torsani; Luigi Camporota; Andreas Schibler; Gerhard K Wolf; Diederik Gommers; Steffen Leonhardt; Andy Adler
Journal:  Thorax       Date:  2016-09-05       Impact factor: 9.139

View more
  3 in total

Review 1.  Mucosa-interfacing electronics.

Authors:  Kewang Nan; Vivian R Feig; Binbin Ying; Julia G Howarth; Ziliang Kang; Yiyuan Yang; Giovanni Traverso
Journal:  Nat Rev Mater       Date:  2022-09-14       Impact factor: 76.679

Review 2.  Unshrinking the baby lung to calm the VILI vortex.

Authors:  Gary Nieman; Michaela Kollisch-Singule; Harry Ramcharran; Joshua Satalin; Sarah Blair; Louis A Gatto; Penny Andrews; Auyon Ghosh; David W Kaczka; Donald Gaver; Jason Bates; Nader M Habashi
Journal:  Crit Care       Date:  2022-08-07       Impact factor: 19.334

3.  Pulmonary rehabilitation ameliorates regional lung function in chronic obstructive pulmonary disease: a prospective single-arm clinical trial.

Authors:  Haiman Ma; Meng Dai; Shuo Wu; Zhanqi Zhao; Yan Zhang; Feng Zhao; Lin Yang; Xinyu Ti; Shuoyao Qu
Journal:  Ann Transl Med       Date:  2022-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.